ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

NCT04205227 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Melanoma
Ovary Cancer
Pancreatic Cancer
Solid Tumor

Interventions

DRUG: ENB003
DRUG: Pembrolizumab

Sponsor

ENB Therapeutics, Inc

Collaborators

[object Object]